C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium.

We investigated the role of c-Kit and the membrane-bound ligand (mbKitL) in endothelial progenitor cell (EPC) recruitment by microvascular endothelial cells (ECs). We demonstrated that inflammatory activation induced the expression of the mbKitL on ECs both in vitro and in vivo, and that recruitment of EPCs depended on c-Kit/mbKitL interaction. Depletion of endogenous c-Kit or inhibition of c-Kit enzymatic activity by imatinib mesylate prevented adhesion of EPCs to activated ECs both in vitro and in vivo, indicating that a functional c-Kit on EPCs is essential. We also demonstrate that Akt was the downstream molecule regulating cell adhesion. A potential role of the c-Kit/mbKitL interaction in pathological settings is sustained by the expression of the mbKitL on ECs lining intraplaque neovessels. Thus, our results provide new insights into the mechanisms underlying EPC recruitment and the bases for novel strategies to hinder pathological angiogenesis.

[1]  K. Welte,et al.  Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation. , 1994, Blood.

[2]  G. Camussi,et al.  Role of L-Selectin in the Vascular Homing of Peripheral Blood-Derived Endothelial Progenitor Cells1 , 2004, The Journal of Immunology.

[3]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[4]  J. Matsui,et al.  Stem Cell Factor/c-kit Signaling Promotes the Survival, Migration, and Capillary Tube Formation of Human Umbilical Vein Endothelial Cells* , 2004, Journal of Biological Chemistry.

[5]  Division on Earth Guide for the Care and Use of Laboratory Animals , 1996 .

[6]  B. Engelhardt,et al.  Multistep Nature of Microvascular Recruitment of Ex Vivo–expanded Embryonic Endothelial Progenitor Cells during Tumor Angiogenesis , 2003, The Journal of experimental medicine.

[7]  M. Cooper,et al.  Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice. , 2005, Journal of the American Society of Nephrology : JASN.

[8]  G. Nickenig,et al.  Clinical and therapeutical implications of EPC biology in atherosclerosis , 2006, Journal of cellular and molecular medicine.

[9]  C. Lange,et al.  Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. , 2005, American journal of physiology. Renal physiology.

[10]  H. Gisslinger,et al.  TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia. , 2004, The Journal of clinical investigation.

[11]  P. Dentelli,et al.  p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes* , 2006, Journal of Biological Chemistry.

[12]  P. Leder,et al.  Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.

[13]  Richard G. W. Anderson,et al.  LRP: Role in Vascular Wall Integrity and Protection from Atherosclerosis , 2003, Science.

[14]  D. Williams,et al.  Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. , 1995, Blood.

[15]  A. Ullrich,et al.  Human proto‐oncogene c‐kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. , 1987, The EMBO journal.

[16]  E. Huang,et al.  Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. , 1992, Molecular biology of the cell.

[17]  B. Leclair,et al.  Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). , 1992, Experimental hematology.

[18]  Y. Kitamura,et al.  Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts , 2005, Laboratory Investigation.

[19]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[20]  P. Dentelli,et al.  IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGFβ activity: potential role in tumor vessel stabilization , 2004, Oncogene.

[21]  H. Gisslinger,et al.  TGF-β1 induces bone marrow reticulin fibrosis in hairy cell leukemia , 2004 .

[22]  W. Muller,et al.  Locomotion of monocytes on endothelium is a critical step during extravasation , 2004, Nature Immunology.

[23]  S. Dimmeler,et al.  Endothelial progenitor cells functional characterization. , 2004, Trends in cardiovascular medicine.

[24]  Protein kinase C-dependent release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-dependent human myeloid cells. , 1994, Oncogene.

[25]  E. Chavakis,et al.  Role of (cid:1) 2-integrins for homing and neovascularization capacity of endothelial progenitor cells , 2004 .

[26]  Alex Matter,et al.  Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug , 2002, Nature Reviews Drug Discovery.

[27]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[28]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[29]  C. Betsholtz,et al.  Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. , 2002, The American journal of pathology.

[30]  M. Brizzi,et al.  Soluble c-kit proteins and antireceptor monoclonal antibodies confine the binding site of the stem cell factor. , 1993, The Journal of biological chemistry.

[31]  G. Camussi,et al.  Altered angiogenesis and survival in human tumor‐derived endothelial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  D. Stupack,et al.  A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. , 2006, The Journal of clinical investigation.

[33]  L. Claesson‐Welsh,et al.  Platelet-derived growth factor receptor- promotes early endothelial cell differentiation , 2006 .

[34]  P. Dentelli,et al.  Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. , 1999, Circulation research.

[35]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.